Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway

about

Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway

Item

http://www.wikidata.org/entity/Q41674995

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Resveratrol inhibits Extranoda ...... of DNA damage response pathway

@en

type

Item

label

Resveratrol inhibits Extranoda ...... of DNA damage response pathway

@en

prefLabel

Resveratrol inhibits Extranoda ...... of DNA damage response pathway

@en

P1476

Resveratrol inhibits Extranoda ...... of DNA damage response pathway

@en

P2093

Bobin Chen

http://www.w3.org/2001/XMLSchema#string

Canjing Zhang

http://www.w3.org/2001/XMLSchema#string

Chen Xu

http://www.w3.org/2001/XMLSchema#string

Feng Tang

http://www.w3.org/2001/XMLSchema#string

Jianan Zhou

http://www.w3.org/2001/XMLSchema#string

Lianhua Yin

http://www.w3.org/2001/XMLSchema#string

Shengxuan Cao

http://www.w3.org/2001/XMLSchema#string

Songmei Wang

http://www.w3.org/2001/XMLSchema#string

Xianxian Sui

http://www.w3.org/2001/XMLSchema#string

Xiuling Zhi

http://www.w3.org/2001/XMLSchema#string

P2860

Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis

Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus

Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation

Therapeutic potential of resveratrol: the in vivo evidence

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

P2888

s13046-017-0601-6

P304

133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13046-017-0601-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091923830

http://www.w3.org/2001/XMLSchema#string

P698

28950914

http://www.w3.org/2001/XMLSchema#string

P921

DNA damage

P932

5615630

http://www.w3.org/2001/XMLSchema#string